Defects in MMR cause hereditary and sporadic cancers.1–5 Recent studies have also shown that tumors’ MMR activity predominantly modulates checkpoint blockade immunotherapy.6–9 Thus, understanding the molecular mechanism of MMR is important for predicting cancer susceptibility and designing effective therapies. Here, MRC1 is linked to cancer.